Altogether, these findings suggest that BET inhibitor-mediated GDF15 inhibition plays a critical role in enhancing sunitinib sensitivity, indicating that BET inhibitors synergize with sunitinib in melanoma. This evidence concerns the gene GDF15 and melanoma.